6/27/2025

Janusmed sex and gender

Janusmed sex and gender – degarelix acetate

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Degarelix

Degarelix

Class : B

Show all info

Print

Contact us

  1. Physicians' Desk Reference. http://www.pdr.net. [cited 2018-12-17].

  2. Fass.se [cited 2018-12-06].

  3. Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H et al. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for . Front Endocrinol (Lausanne). 2018;9(1):25.

  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-12-17.]

  5. Concise. Kalmar: eHälsomyndigheten. 2015 [cited 2018-12-17.]

  1. Physicians' Desk Reference. http://www.pdr.net. [cited 2018-12-17].
  2. Fass.se [cited 2018-12-06].
  3. Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H et al. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for . Front Endocrinol (Lausanne). 2018;9(1):25.
  4. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2017 [cited 2018-12-17.]
  5. Concise. Kalmar: eHälsomyndigheten. 2015 [cited 2018-12-17.]